• Something wrong with this record ?

A combination of GRA3, GRA6 and GRA7 peptides offer a useful tool for serotyping type II and III Toxoplasma gondii infections in sheep and pigs

D. Arranz-Solís, LR. Tana, E. Tejerina-de-Uribe, NM. López-Ureña, B. Koudela, ME. Francia, LM. Ortega-Mora, G. Álvarez-García

. 2024 ; 14 (-) : 1384393. [pub] 20240424

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc24014261

The clinical consequences of toxoplasmosis are greatly dependent on the Toxoplasma gondii strain causing the infection. To better understand its epidemiology and design appropriate control strategies, it is important to determine the strain present in infected animals. Serotyping methods are based on the detection of antibodies that react against segments of antigenic proteins presenting strain-specific polymorphic variations, offering a cost-effective, sensitive, and non-invasive alternative to genotyping techniques. Herein, we evaluated the applicability of a panel of peptides previously characterized in mice and humans to serotype sheep and pigs. To this end, we used 51 serum samples from experimentally infected ewes (32 type II and 19 type III), 20 sheep samples from naturally infected sheep where the causative strain was genotyped (18 type II and 2 type III), and 40 serum samples from experimentally infected pigs (22 type II and 18 type III). Our ELISA test results showed that a combination of GRA peptide homologous pairs can discriminate infections caused by type II and III strains of T. gondii in sheep and pigs. Namely, the GRA3-I/III-43 vs. GRA3-II-43, GRA6-I/III-213 vs. GRA6-II-214 and GRA6-III-44 vs. GRA6-II-44 ratios showed a statistically significant predominance of the respective strain-type peptide in sheep, while in pigs, in addition to these three peptide pairs, GRA7-II-224 vs. GRA7-III-224 also showed promising results. Notably, the GRA6-44 pair, which was previously deemed inefficient in mice and humans, showed a high prediction capacity, especially in sheep. By contrast, GRA5-38 peptides failed to correctly predict the strain type in most sheep and pig samples, underpinning the notion that individual standardization is needed for each animal species. Finally, we recommend analyzing for each animal at least 2 samples taken at different time points to confirm the obtained results.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24014261
003      
CZ-PrNML
005      
20240905134223.0
007      
ta
008      
240725e20240424sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fcimb.2024.1384393 $2 doi
035    __
$a (PubMed)38720960
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Arranz-Solís, David $u SALUVET group, Faculty of Veterinary Sciences, Animal Health Department, Complutense University of Madrid, Madrid, Spain
245    12
$a A combination of GRA3, GRA6 and GRA7 peptides offer a useful tool for serotyping type II and III Toxoplasma gondii infections in sheep and pigs / $c D. Arranz-Solís, LR. Tana, E. Tejerina-de-Uribe, NM. López-Ureña, B. Koudela, ME. Francia, LM. Ortega-Mora, G. Álvarez-García
520    9_
$a The clinical consequences of toxoplasmosis are greatly dependent on the Toxoplasma gondii strain causing the infection. To better understand its epidemiology and design appropriate control strategies, it is important to determine the strain present in infected animals. Serotyping methods are based on the detection of antibodies that react against segments of antigenic proteins presenting strain-specific polymorphic variations, offering a cost-effective, sensitive, and non-invasive alternative to genotyping techniques. Herein, we evaluated the applicability of a panel of peptides previously characterized in mice and humans to serotype sheep and pigs. To this end, we used 51 serum samples from experimentally infected ewes (32 type II and 19 type III), 20 sheep samples from naturally infected sheep where the causative strain was genotyped (18 type II and 2 type III), and 40 serum samples from experimentally infected pigs (22 type II and 18 type III). Our ELISA test results showed that a combination of GRA peptide homologous pairs can discriminate infections caused by type II and III strains of T. gondii in sheep and pigs. Namely, the GRA3-I/III-43 vs. GRA3-II-43, GRA6-I/III-213 vs. GRA6-II-214 and GRA6-III-44 vs. GRA6-II-44 ratios showed a statistically significant predominance of the respective strain-type peptide in sheep, while in pigs, in addition to these three peptide pairs, GRA7-II-224 vs. GRA7-III-224 also showed promising results. Notably, the GRA6-44 pair, which was previously deemed inefficient in mice and humans, showed a high prediction capacity, especially in sheep. By contrast, GRA5-38 peptides failed to correctly predict the strain type in most sheep and pig samples, underpinning the notion that individual standardization is needed for each animal species. Finally, we recommend analyzing for each animal at least 2 samples taken at different time points to confirm the obtained results.
650    _2
$a zvířata $7 D000818
650    _2
$a protilátky protozoální $x krev $7 D000913
650    12
$a antigeny protozoální $x genetika $x imunologie $7 D000953
650    _2
$a ELISA $x metody $7 D004797
650    _2
$a genotyp $7 D005838
650    _2
$a peptidy $x imunologie $7 D010455
650    12
$a sérotypizace $x metody $7 D012703
650    _2
$a ovce $7 D012756
650    12
$a nemoci ovcí $x parazitologie $x diagnóza $7 D012757
650    _2
$a prasata $7 D013552
650    12
$a nemoci prasat $x parazitologie $x diagnóza $7 D013553
650    12
$a toxoplazmóza zvířat $x diagnóza $x parazitologie $7 D014124
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Tana, Leandro R $u Laboratory of Apicomplexan Biology, Institut Pasteur de Montevideo, Montevideo, Uruguay
700    1_
$a Tejerina-de-Uribe, Eduardo $u SALUVET group, Faculty of Veterinary Sciences, Animal Health Department, Complutense University of Madrid, Madrid, Spain
700    1_
$a López-Ureña, Nadia María $u SALUVET group, Faculty of Veterinary Sciences, Animal Health Department, Complutense University of Madrid, Madrid, Spain
700    1_
$a Koudela, Břetislav $u Central European Institute of Technology (CEITEC), University of Veterinary Sciences, Brno, Czechia $u Faculty of Veterinary Medicine, University of Veterinary Sciences, Brno, Czechia $u Veterinary Research Institute, Brno, Czechia
700    1_
$a Francia, María E $u Laboratory of Apicomplexan Biology, Institut Pasteur de Montevideo, Montevideo, Uruguay
700    1_
$a Ortega-Mora, Luis Miguel $u SALUVET group, Faculty of Veterinary Sciences, Animal Health Department, Complutense University of Madrid, Madrid, Spain
700    1_
$a Álvarez-García, Gema $u SALUVET group, Faculty of Veterinary Sciences, Animal Health Department, Complutense University of Madrid, Madrid, Spain
773    0_
$w MED00182987 $t Frontiers in cellular and infection microbiology $x 2235-2988 $g Roč. 14 (20240424), s. 1384393
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38720960 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134217 $b ABA008
999    __
$a ok $b bmc $g 2143822 $s 1226127
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 14 $c - $d 1384393 $e 20240424 $i 2235-2988 $m Frontiers in cellular and infection microbiology $n Front Cell Infect Microbiol $x MED00182987
LZP    __
$a Pubmed-20240725

Find record

Citation metrics

Archiving options